These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 3263759)

  • 1. Variability of methotrexate pharmacokinetics and pharmacodynamics.
    Dawson AH; Grygiel JJ
    Agents Actions Suppl; 1988; 24():226-35. PubMed ID: 3263759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methotrexate pharmacokinetics in patients with rheumatoid arthritis.
    Sinnett MJ; Groff GD; Raddatz DA; Franck WA; Bertino JS
    J Rheumatol; 1989 Jun; 16(6):745-8. PubMed ID: 2674426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimising low-dose methotrexate for rheumatoid arthritis-A review.
    Lucas CJ; Dimmitt SB; Martin JH
    Br J Clin Pharmacol; 2019 Oct; 85(10):2228-2234. PubMed ID: 31276602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes related to methotrexate dose and route of administration in patients with rheumatoid arthritis: a systematic literature review.
    Goodman SM; Cronstein BN; Bykerk VP
    Clin Exp Rheumatol; 2015; 33(2):272-8. PubMed ID: 25536122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of correlation between pharmacokinetics and efficacy of low dose methotrexate in patients with rheumatoid arthritis.
    Lafforgue P; Monjanel-Mouterde S; Durand A; Catalin J; Acquaviva PC
    J Rheumatol; 1995 May; 22(5):844-9. PubMed ID: 8587070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methotrexate and Rheumatoid Arthritis: Current Evidence Regarding Subcutaneous Versus Oral Routes of Administration.
    Bianchi G; Caporali R; Todoerti M; Mattana P
    Adv Ther; 2016 Mar; 33(3):369-78. PubMed ID: 26846283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The frequency and clinical characteristics of methotrexate (MTX) oral toxicity in rheumatoid arthritis (RA): a masked and controlled study.
    Ince A; Yazici Y; Hamuryudan V; Yazici H
    Clin Rheumatol; 1996 Sep; 15(5):491-4. PubMed ID: 8894364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Splitting high-dose oral methotrexate improves bioavailability: a pharmacokinetic study in patients with rheumatoid arthritis.
    Hoekstra M; Haagsma C; Neef C; Proost J; Knuif A; van de Laar M
    J Rheumatol; 2006 Mar; 33(3):481-5. PubMed ID: 16463431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmacokinetics of methotrexate in rheumatoid arthritis: therapeutic implications].
    Bannwarth B; Péhourcq F; Lequen L
    Therapie; 1997; 52(2):129-32. PubMed ID: 9231507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioavailability of higher dose methotrexate comparing oral and subcutaneous administration in patients with rheumatoid arthritis.
    Hoekstra M; Haagsma C; Neef C; Proost J; Knuif A; van de Laar M
    J Rheumatol; 2004 Apr; 31(4):645-8. PubMed ID: 15088287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determinants of red blood cell methotrexate polyglutamate concentrations in rheumatoid arthritis patients receiving long-term methotrexate treatment.
    Stamp LK; O'Donnell JL; Chapman PT; Zhang M; Frampton C; James J; Barclay ML
    Arthritis Rheum; 2009 Aug; 60(8):2248-56. PubMed ID: 19644853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Practical clinical pharmacology and drug interactions of low-dose methotrexate therapy in rheumatoid arthritis.
    Furst DE
    Br J Rheumatol; 1995 Nov; 34 Suppl 2():20-5. PubMed ID: 8535644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methotrexate in rheumatoid arthritis: optimizing therapy among different formulations. Current and emerging paradigms.
    Cipriani P; Ruscitti P; Carubbi F; Liakouli V; Giacomelli R
    Clin Ther; 2014 Mar; 36(3):427-35. PubMed ID: 24612941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination therapy with methotrexate and hydroxychloroquine for rheumatoid arthritis increases exposure to methotrexate.
    Carmichael SJ; Beal J; Day RO; Tett SE
    J Rheumatol; 2002 Oct; 29(10):2077-83. PubMed ID: 12375315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chloroquine reduces the bioavailability of methotrexate in patients with rheumatoid arthritis. A possible mechanism of reduced hepatotoxicity.
    Seideman P; Albertioni F; Beck O; Eksborg S; Peterson C
    Arthritis Rheum; 1994 Jun; 37(6):830-3. PubMed ID: 8003056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of etodolac on methotrexate pharmacokinetics in patients with rheumatoid arthritis.
    Anaya JM; Fabre D; Bressolle F; Bologna C; Alric R; Cocciglio M; Dropsy R; Sany J
    J Rheumatol; 1994 Feb; 21(2):203-8. PubMed ID: 8182625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methotrexate in rheumatoid arthritis.
    Furst DE; Kremer JM
    Arthritis Rheum; 1988 Mar; 31(3):305-14. PubMed ID: 2965875
    [No Abstract]   [Full Text] [Related]  

  • 18. Methotrexate Dose in Patients With Early Rheumatoid Arthritis Impacts Methotrexate Polyglutamate Pharmacokinetics, Adalimumab Pharmacokinetics, and Efficacy: Pharmacokinetic and Exposure-response Analysis of the CONCERTO Trial.
    Goss SL; Klein CE; Jin Z; Locke CS; Rodila RC; Kupper H; Burmester GR; Awni WM
    Clin Ther; 2018 Feb; 40(2):309-319. PubMed ID: 29402521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The importance of inhibition of a catabolic pathway of methotrexate metabolism in its efficacy for rheumatoid arthritis.
    Morgan SL; Baggott JE
    Med Hypotheses; 2019 Jan; 122():10-15. PubMed ID: 30593388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of interaction between bromfenac and methotrexate in patients with rheumatoid arthritis.
    Gumbhir-Shah K; Cevallos WH; DeCleene SA; Korth-Bradley JM
    J Rheumatol; 1996 Jun; 23(6):984-9. PubMed ID: 8782127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.